CORZR
Core Scientific, Inc./tx
Key Financials
Operating Income
$-245589000
↓ 1179.4%
Net Income
$-288616000
↑ 78.1%
Total Assets
$2.3B
↑ 46.8%
Shareholders' Equity
$-962740000.00
↓ 17.4%
Revenue
$319.0M
↓ 37.5%
EPS (Diluted)
$-0.88
↑ 80.0%
Total Liabilities
$3.3B
↑ 36.8%
Gross Profit
$37.9M
↓ 68.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/20/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 8-K | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 4 | 5/13/2026 | View on SEC |
| 3 | 5/11/2026 | View on SEC |
| 10-Q | 5/6/2026 | View on SEC |
| 4 | 5/6/2026 | View on SEC |
| 8-K | 5/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CORZR |
| Company Name | Core Scientific, Inc./tx |
| CIK | 1839341 |
| Sector | Finance Services |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 6199 |
| SIC Description | Finance Services |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (425) 998-5300 |